Table 2.
Samplings proposed to the INSPIRE Human Translational Research Cohort participants for the creation of the biobank
| Biospecimens | At inclusion | Every Year | Every2years | Types of analyses |
|---|---|---|---|---|
| Blood (60 ml each visit) | ✓ | ✓ | MultiOMICs analyses (proteomic, lipidomic, metabolomic, transcriptomic) SARS COV-2 infection | |
| Nasopharyngeal sample | ✓ | ✓ | Carrying the respiratory syncytial virus, influenza virus and Clostridium difficile | |
| Urine (20 ml at each visit) | ✓ | ✓ | MultiOMICs analyses | |
| Saliva (10 ml at each visit) | ✓ | ✓ | Metabolomic Analyses, Proteomic Analyses | |
| Dental plaque | ✓ | ✓ | Metabolomic Analyses Microbiome | |
| Skin samples: | ||||
| ‐swabbing, delamination | ✓ | ✓ | Proteomic and lipidomic analyses, Microbiome | |
| ‐skin biopsy (optional) | ✓ | Amplification and biobanking of human fibroblasts, generation of IPS cells | ||
| Hair bulb (optional) | ✓ | Proteomic/transcriptomic analysis Oxy-proteome | ||
| Feces (optional) | ✓ | Microbiome |